Sign In
Buy EYPT
$12.25
-0.610 (-4.74%)
At Close: Jul 31, 2026
Nicox : La trésorerie de Nicox grimpe à 47 millions d'euros grâce au renforcement de l'accord avec Ocumension
10:00am, Wednesday, 11'th Mar 2020
(BFM Bourse) - La société chinoise d'ophtalmologie distribuera les produits de Nicox à un plus large échelon en Asie et a convenu de prendre à sa charge …
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT) and Aurinia Pharmaceuticals (AUPH)
12:23pm, Friday, 06'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on EyePoint Pharmaceuticals (EYPT) and Aurinia
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on EyePoint Pharmaceuticals (
EYPT
–
Research Report
) and Aurinia Pharmaceuticals (
AUPH
–
Research R
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
01:05pm, Thursday, 05'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In
EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Corporate Progress
12:00pm, Thursday, 05'th Mar 2020
– Total revenues of $8.6 million in Q4 2019 and $20.4 million for full year 2019 – – Net product revenues of $7.9 million in Q4 2019 and $16.8 million for full year 2019 –.
Analysts Conflicted on These Healthcare Names: EyePoint Pharmaceuticals (EYPT), uniQure (QURE) and Heron Therapeutics (HRTX)
12:10pm, Tuesday, 03'rd Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on EyePoint Pharmaceuticals (EYPT), uniQure (QURE) and Heron
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on EyePoint Pharmaceuticals (
EYPT
–
Research Report
), uniQure (
QURE
–
Research Report
) and Heron T
EyePoint Pharmaceuticals Announces Positive Topline 36-month Follow-up Data for Second Phase 3 Study of YUTIQ®
12:00pm, Monday, 02'nd Mar 2020
EyePoint Pharmaceuticals, Inc. (EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced positive topline 36-month follow-up data fr
The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
07:52pm, Saturday, 29'th Feb 2020
Biotech stocks came under significant weakness along with the broader market in the week ended Feb. 28. Despite fears the COVID-19 epidemic will likely drag global growth, the viral outbreak proved ad
EyePoint Pharmaceuticals Announces Fourth Quarter and Full-Year 2019 Financial Results Release Date and Conference Call Information
12:00pm, Thursday, 27'th Feb 2020
WATERTOWN, Mass., Feb. 27, 2020 -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic.
EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
02:09pm, Friday, 21'st Feb 2020
EyePoint Pharmaceuticals, Inc. (EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products today announced the pricing of an underwritten public off
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
12:46pm, Friday, 21'st Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose B
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
09:01pm, Thursday, 20'th Feb 2020
EyePoint Pharmaceuticals, Inc. (EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that it intends to offer and sell shares
EyePoint Pharmaceuticals and Vision Center Network of America Sign Purchase Agreement for DEXYCU®
12:00pm, Tuesday, 18'th Feb 2020
EyePoint Pharmaceuticals, Inc. (EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, and Vision Center Network of America, LLC (“VCNA”),
